Ca, cAMP & Lipid Signaling

Phospho-PKC Antibody Sampler Kit

イイネ!(0)
CSTコード 包装
希望納入価格 (円)
国内在庫 i
2012年2月3日18時20分 現在
ご登録代理店情報 i
カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更はこちら
#9921S1 Kit126,000
ログインすると国内在庫状況がご確認いただけます。

PKC抗体製品一覧

9921 の推奨プロトコール i

最適な結果を得るために:Cell Signaling Technology (CST) 社は、各製品の推奨プロトコールを使用することを強くお薦めいたします。
推奨プロトコールはCST社内試験の徹底的なバリデーションに基づいて作成されておりますので、正確かつ再現性の高い結果が得られます。

注:各製品に最適化されたプロトコールをリンクしています。

 
キット内容 容量 用途 種交差性 検出タンパク質の分子量 Isotype
Phospho-PKD/PKCmu (Ser916) Antibody #2051 40 µl W IP H M R Mk 115 Rabbit
PKD/PKCμ Antibody #2052 40 µl W F H M R Mk 115 Rabbit
Phospho-PKD/PKCmu (Ser744/748) Antibody #2054 40 µl W H M R Mk 115 Rabbit
Phospho-PKC (pan) (βII Ser660) Antibody #9371 40 µl W H M R Mk 78, 80, 82, 85 Rabbit
Phospho-PKCalpha/beta II (Thr638/641) Antibody #9375 40 µl W IP H M Mk (R) (Hm) 80, 82 Rabbit
Phospho-PKCdelta (Thr505) Antibody #9374 40 µl W H M R 78 Rabbit
Phospho-PKCδ/θ (Ser643/676) Antibody #9376 40 µl W IHC-P H M R Mk X 78 Rabbit
Phospho-PKCtheta (Thr538) Antibody #9377 40 µl W H R Mk B (M) 79 Rabbit
Phospho-PKCzeta/lambda (Thr410/403) Antibody #9378 40 µl W H M R Mk 76 Rabbit
Anti-rabbit IgG, HRP-linked Antibody #7074 100 µl Goat
貯法
-20℃
※括弧付きの動物種は配列が100%相同であるため反応すると推定されます。
社内データ

Western Blotting

Western Blotting

Western blot analysis of extracts from NIH3T3 cells (lanes 1 & 2) and HeLa cells (lanes 3 & 4), untreated (lanes 1 & 3), PGDF-treated (lane 2), and TNFα-treated (lane 4), using Phospho- PKCζ/λ (Thr410/403) Antibody #9378, and PKCζ Antibody #9368.

Western Blotting

Western Blotting

Western blot analysis of extracts from 293 cells, untreated (lane 1), TPA-treated (.2μM for 20 minutes) (lanes 2 & 3), and CIP/λ phosphatase treated (lane 3), using Phospho-PKC (pan) (βII Ser660) Antibody #9371, Phospho-PKCα/βII (Thr638/641) Antibody #9375, and PKCα Antibody #2056.

Western Blotting

Western Blotting

Western blot analysis of extracts from C6 cells (lanes 1 & 2) and COS cells (lanes 3 & 4), untreated (lanes 1 & 3), or TPA-treated (.2μM for 20 minutes) (lanes 2 & 4), using Phospho-PKD/PKCμ (Ser916) Antibody #2051, Phospho-PKD/PKCμ (Ser744/748) Antibody #2054, PKD/PKCμ Antibody #2052, and β-actin Antibody #4967.


Western Blotting

Western Blotting

Western blot analysis of extracts from HeLa cells, untreated (lane 1), TPA-treated (0.2 μM for 20 minutes) (lanes 2 & 3), and CIP/λ phosphatase treated (lane 3), using Phospho- PKCδ (Thr505) Antibody #9374, PKCδ Antibody #2058, and β-actin Antibody #4967.

Western Blotting

Western Blotting

Western blot analysis of extracts from 293 cells, untreated (lane 1), TPA-treated (.2μM for 20 minutes) (lanes 2 & 3), and CIP/λ phosphatase treated (lane 3), using Phospho-PKCδ/θ (Ser643/676) Antibody #9376, Phospho-PKCθ (Thr538) Antibody #9377, PKCθ Antibody #2059, and β-actin Antibody #4967.

バックグラウンド

Activation of protein kinase C (PKC) is one of the earliest events in a cascade that controls a variety of cellular responses, including secretion, gene expression, proliferation, and muscle contraction (1,2). PKC isoforms belong to three groups based on calcium dependency and activators. Classical PKCs are calcium-dependent via their C2 domains and are activated by phosphatidylserine (PS), diacylglycerol (DAG), and phorbol esters (TPA, PMA) through their cysteine-rich C1 domains. Both novel and atypical PKCs are calcium-independent, but only novel PKCs are activated by PS, DAG, and phorbol esters (3-5). Members of these three PKC groups contain a pseudo-substrate or autoinhibitory domain that binds to substrate-binding sites in the catalytic domain to prevent activation in the absence of cofactors or activators. Control of PKC activity is regulated through three distinct phosphorylation events. Phosphorylation at Thr500 in the activation loop, the autophosphorylation site at Thr641, and at carboxy-terminal hydrophobic site Ser660 occurs in vivo (2). Atypical PKC isoforms lack hydrophobic region phosphorylation, which correlates with the presence of glutamic acid rather than the serine or threonine residues found in more typical PKC isoforms. Either the enzyme PDK1 or a close relative is responsible for PKC activation. A recent addition to the PKC superfamily is PKCμ (PKD), which is regulated by DAG and TPA through its C1 domain. PKD is distinguished by the presence of a PH domain and by its unique substrate recognition and Golgi localization (6). PKC-related kinases (PRK) lack the C1 domain and do not respond to DAG or phorbol esters. Phosphatidylinositol lipids activate PRKs and small Rho-family GTPases bind to the homology region 1 (HR1) to regulate PRK kinase activity (7).

  1. Nishizuka, Y. (1984) Nature 308, 693-698.
  2. Keranen, L.M. et al. (1995) Curr. Biol. 5, 1394-1403.
  3. Mellor, H. and Parker, P.J. (1998) Biochem J. 332 (Pt 2), 281-292.
  4. Ron, D. and Kazanietz, M.G. (1999) FASEB J. 13, 1658-1676.
  5. Moscat, J. and Diaz-Meco, M.T. (2000) EMBO Rep. 1, 399-403.
  6. Baron, C.L. and Malhotra, V. (2002) Science 295, 325-328.
  7. Flynn, P. et al. (2000) J. Biol. Chem. 275, 11064-11070.
使用例
製品をご使用いただいて研究を発表されましたら、ぜひお知らせください
 
関連製品
2056   PKCα Antibody
2058   PKCδ Antibody
2261   Phospho-(Ser) PKC Substrate Antibody
7003   20X LumiGLO® Reagent and 20X Peroxide
7074   Anti-rabbit IgG, HRP-linked Antibody
7720   Prestained Protein Marker, Broad Range (Premixed Format)
7727   Biotinylated Protein Ladder Detection Pack
9379   Phospho-PKC (pan) (γ Thr514) Antibody

本製品は試験研究用です。

Phospho-PKC Antibody Sampler Kit

Product Pathways

Tools

Applications